Imaging agents Lexiscan and Adenoscan have been used for years to aid clinicians in performing nucleur cardiac stress diagnostic tests. This week, FDA released information stating these imaging agents have caused heart attacks in stress test patients.
Since its inception in 1995, thousands of patients have underwent non-exercised based stress tests using Adenoscan imaging agents. Later, Lexiscan was introduced to the market for myocardial profusion tests. These imaging agents revolutionized the way clinicians conducted the stress test, allowing patients who cannot undergo extreme cardio exercise to be tested for cardiac-related disease.
The Lexiscan and Adenscan products were recently added to the quarterly list of drugs to monitor in September of this year when an increase of patient who were administered the drug ended up suffering from severe myocardial infractions. Over 29 patients have lost their lives to MI since the drug’s implementation, countless others have faced serious cardiovascular issues and disease.
The most common affliction associated with Lexiscan and Adenoscan are:
Myocardial infractions or MI
The Lexiscan Adenoscan FDA heart attack warning label will soon be added to the packaging. In the mean time, patients who are about to undergo a nuclear stress test, be aware. Your clinician should ensure resuscitation equipment is on hand during the procedure, offer you alternative imaging agents for the test, determine cardio stress test fitness before administering the nuclear stress test.
If you or a love one has suffered an affliction due to the administration of Lexiscan or Adenoscan, it is important you seek legal advice immediately. The lawyers at The Levensten Law Firm understand you have you and your loved ones have suffered as a result of big drug company negligence. Please contact us for a consultation. Our attorneys are dedicated to helping you receive compensation for medical expenses as well as emotional pain and suffering due to dangerous drugs.